covid vaccine and wound healing10 marca 2023
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). doi: 10.1038/s41591-020-1124-9, 3. https://acwound.org/college/index.php.html, The paper describes the complexity of wound care patients, the unintended consequences of decreasing necessary medical care during the pandemic, and potential solutions, such as telemedicine that can provide a "bridge" between face to face visits for these patients. Scar formation was evaluated according to the Patient and Observer Scar Assessment Scale (POSAS) after a 3-month follow-up. Remarks by Dr. Hahn to the Global Coalition for Regulatory Science Research, Dr. Hahn's remarks to the National Consumers League on the vaccine review process, Consumer Perspectives on the Covid-19 Pandemic: A Conversation with the FDA, Remarks by Commissioner Hahn to Friends of Cancer Research, COVID-19: An Update on the Federal Response - FDA Opening Remarks. (A) WAI at 7 d follow-up; (B) POSAS patient scale at three-month follow-up; (C). Today, the U.S. Food and Drug Administration announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee to discuss the matter of additional doses of COVID-19 vaccines and specifically to discuss the Pfizer-BioNTech supplemental Biologics License Application for administration of a third (booster) dose of Comirnaty (COVID-19 Vaccine, mRNA) in individuals 16 years of age and older. However, in the 21st century, 2 highly pathogenic HCoVssevere acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)emerged from animal reservoirs to cause global epidemics with alarming . Educating patients and their families about how to manage ongoing holistic health needs. (2021) 596:41722. Dermatologic side effects and cutaneous reactions, such as local injection site reactions, morbilliform rash, pernio, pityriasis rosea, and erythema multiforme, due to the COVID-19 vaccine are very common (22). We'll make sure they're safe and effective. FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for the use of a single booster dose, to be administered at least six months after completion of the primary series with the Pfizer-BioNTech COVID-19 Vaccine in certain populations. In the light of this recent investigation, does the Commission intend to have an independent laboratory perform a careful analysis to check for the presence of graphene in the COVID-19 vaccines? An official website of the United States government. Ginandes C, Brooks P, Sando W, Jones C, Aker J. Today, the FDA authorized a manufacturing change for the Moderna COVID-19 Vaccine to include an additional presentation of the vaccine for booster vaccination doses only. Lim DW, Ng D, Low JG. Following todays positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 Vaccine, the FDA has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization. The FDAs Vaccines and Related Biological Products Advisory Committee and its Role in Advising the Agency on COVID-19 Vaccines. 1-844-802-3925 . Your COVID-19 vaccine is free. ET. Informing evidence-based and cost-efficient care decisions for WOC patients as interdisciplinary health team members. Careers. Huang Z, Su Y, Zhang T, Xia N. A review of the safety and efficacy of current COVID-19 vaccines. FDA In Brief: FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTechs Application for COVID-19 Booster. The vaccination interval was defined as the interval between the last dose of the COVID-19 vaccine and when surgical sutures were introduced. On Wednesday, the FDA authorized the Novavax COVID-19 Vaccine, Adjuvanted for use as a first booster dose to individuals 18 years of age and older for whom an FDA . PMC As of January 18th, 2021, over 715,072 COVID-19 cases have been confirmed in Canada with 240,348 of those cases located in Ontario. View livestream recording. For example, patients with non-healing wounds are 20 times more likely to need inpatient care or to visit the Emergency Room. (A) vascularization; (B) pigmentation; (C) thickness; (D) relief; (E) pliability. Accessibility Statement by FDA Commissioner Stephen M. Hahn, M.D., and Center for Biologics Evaluation and Research Director Peter Marks, M.D., Ph.D. Coronavirus (COVID-19) Update: FDA Holds Advisory Committee Meeting to Discuss Authorization of COVID-19 Vaccine Candidate as Part of Agencys Review of Safety and Effectiveness Data. ATENCIN: si habla espaol, tiene a su disposicin servi cios gratuitos de asistencia lingu.stica. Therefore, it is unnecessary to postpone COVID-19 vaccination in patients undergoing surgery if they are concerned that the vaccine affects wound healing and scar formation. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. An internal Nurses Specialized in Wound, Ostomy and Continence Canada report confirms this gap in care as only 69 NSWOCs reported providing care support to LTC clients in Canada while only 20 of those NSWOCS are solely dedicated to work in LTC. Your use of this website constitutes acceptance of Haymarket MediasPrivacy PolicyandTerms & Conditions. This study aimed to eliminate concerns and hesitancy in receiving the COVID-19 vaccine. Bookshelf Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting. I'm a disabled woman of color. View press briefing. Berninghausen LK, Osterhoff G, Langer S, Kohler LH. JW: analyzing data and editing the manuscript. In our daily clinical practice, concerns about vaccine safety are manifested in the thought that vaccination may be detrimental to wound healing and result in scar formation after surgery, which is a common concern of patients we have treated during the pandemic. (2014) 67:101725. Science. The committee will meet in open session to discuss a request to amend Pfizer-BioNTechs Emergency Use Authorization (EUA) for administration of their COVID-19 mRNA vaccine to children 5 through 11 years of age. FDA is committed to making decisions regarding the authorization or approval of COVID-19 vaccines that are guided by science and data. By Akshay Syal, M.D. Once we received the Emergency Use Authorization (EUA), I got the vaccine that day. ", Health Fraud & COVID-19: What You Need to Know. See this image and copyright information in PMC. I hope that they have the faith to go get the vaccine.. Dr. William J. Ennis, President of the College and a Professor of Surgery at the University of Illinois Chicago state "We need to be able to use technology such as telemedicine to triage cases that need to be seen face to face and manage some cases virtually during this pandemic and likely into the next several months." Dr. Judy McMeekin, the Associate Commissioner for Regulatory Affairs, joins Dr. Shah on the show to discuss FDA's fight against health fraud during the COVID-19 pandemic. FDA leadership outlines steps the FDA will take to ensure the safety and efficacy of COVID-19 vaccines for young children. Kupferschmidt K. Top Israeli immunologist's views on vaccines trigger furor. National Consumer Protection Week: FDA Is Vigilant in Protecting Consumers Against COVID-19 Vaccine Scams. FDAsCenter for Biologics Evaluation and Research (CBER)regulates vaccines and other biological products. Coronavirus (COVID-19) Update: FDA Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age. 85% of our Mercy physicians have already received the vaccine because theyre listening to the science., Dr. John Mohart continued by sharing the urgency of the situation in terms of the vaccines availability, As health care workers, weve had a monopoly on access to the vaccine, but those days are coming to an end. Details of patients' characteristics were shown in Table 1. Vaccines designed to elicit protective immune responses remain key for containing the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). COVID-19 is highly contagious and its rapid spread burdens the healthcare system. The FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH. Bethesda, MD 20894, Web Policies (2004) 113:19605; discussion 19667. The authorization was based on the FDAs thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group. COVID-19; coronavirus; pandemic; severe acute respiratory syndrome; telemedicine; wound; wound care. The investigators examined the NHS records of 32 million adults in England to assess any rare adverse events linked to Covid vaccines. The doctors explained why each of these fears are untrue. An FDA staff memberdiscusses how her former hesitancy and fear grew into hope and a willingness to receive a COVID-19 vaccine. As the public health agency responsible for regulating medical products, we must ensure that health care providers have the most up-to-date diagnostics, treatments and vaccines in their toolbox to fight this pandemic. -, Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. This vaccine is a miracle and its our only way out., She says the vaccine is, "Our greatest and only hope of emerging from this pandemic, and moving on to a brighter future. 2015 Apr;72(4):668-73. doi: 10.1016/j.jaad.2014.11.032. The report identified a lack of resources within LTC facilities to adequately assess and treat these patients independently as they heavily relied on outside consultation which provided delayed and fragmented care. FDA Commissioner Dr. Steven Hahn spoke about the COVID-19 vaccine development process and other medical countermeasures for COVID-19. The FDA posts an updated letter of authorization, health care provider fact sheet and frequently asked questions regarding the number of Pfizer-BioNTech doses in a vial, updated the Device Shortage List, and provides a testing update. The FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc. Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus Variants. Dr. John Mohart added his thoughts on the most compelling reasons for co-workers to take action and get the vaccine. Vaccine Ready: Addressing COVID-19 Health Disparities among Racial and Ethnic Minority Communities. Copyright 2022 Dong, Yu, Quan, Wei, Wang and Ma. Public health and medical experts from the U.S. Department of Health and Human Services released a statement on the Administrations plan for COVID-19 booster shots for the American people. Cutaneous small-vessel vasculitis after ChAdOx1 COVID-19 vaccination: a report of five cases. Numbers of patients in groups of <1 month, 13 months, and 3 months were 8, 11, and 12, respectively. and the Director of FDA's Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., discuss the suggested increased risks of myocarditis and pericarditis following COVID19 vaccination. doi: 10.1080/00029157.2003.10403546, 17. Please enable it to take advantage of the complete set of features! FDA and EMA Collaborate to Facilitate SARS-CoV-2 Vaccine Development. Ruf selli Nummer uff: Call 1-844-372-8349. Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. COVID-19: Update on Progress Toward Safely Getting Back to Work and Back to School, Hearing before the Senate Committee on Health, Education, Labor and Pensions; FDA Commissioner Stephen M. Hahn, M.D., testifiedfor the FDA.Written testimony, Coronavirus (COVID-19) Update: FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines. (2021) 85:4655. Justus-Liebig University Giessen Department of Oral and Maxillofacial Surgery, Germany, University of Arkansas for Medical Sciences, United States, Panimalar Medical College Hospital and Research Institute, India. Management of diabetic persons with foot ulceration during COVID-19 health care emergency: Effectiveness of a new triage pathway. Epub 2020 Jul 25. Patients such as Lilly deserve better. Sun Q, Fathy R, McMahon DE, Freeman EE. A billboard promotes Covid-19 vaccinations in Times Square in New York last month. Vaccines. Americans who have been fully vaccinated do not need a booster shot at this time. and transmitted securely. Peter W. Marks, M.D., Ph.D. and Stephen M. Hahn, M.D. Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants. Values of p < 0.05 were considered statistically significant. ZY: concept of the study, designing the study, acquiring data, and writing the manuscript. COVID-19 vaccines help protect against severe illness, hospitalization and death. J Am Acad Dermatol. The Critical Role of Health Care Practitioners during COVID-19. The study analyzes which people have Stress and anxiety with Wound infection. Stress and anxiety is found among people with Wound infection, especially for people who are female, 60+ old. FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine. Cureus. On Thursday, FDA approved a single dose vial presentation of COMIRNATY (COVID-19 Vaccine, mRNA). FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted. MeSH Recently, new-onset autoimmune phenomena after COVID-19 vaccination have been reported increasingly (e.g. FOIA The vaccine developers report that some people experience pain where they were injected; body aches; headaches or fever, lasting for a day or two. Today, the FDA issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In Part 1 of FDA Insights vaccine series, Dr. Shah welcomes Dr. Peter Marks, director of FDAs Center for Biologics Evaluation and Research, to discuss the basics of COVID-19 vaccine development. 2020 May;21(4):301-308. doi: 10.1089/sur.2020.101. McMahon et al. In patients who received inactivated vaccine, no statistically significant difference was observed both in wound healing and scar formation among the three groups of <1, 13, and 3 months (WAI: p = 0.553; POSAS patient scale: p = 0.399; POSAS observer scale: p = 0.976). Hospital News Canada, Digital healthcare start-ups building solutions for aging adults to watch for 2021, Triage in critical care: A protocol to protect lives and principles, Creating the Sharing Circle website : Providing culturally safe information to support wound, ostomy and continence care in Indigenous communities, Brainstorming ways to bring wound care directly to those in need, Harm reduction dispensing machines to be installed across Canada, Saving organs, saving lives: Building the worlds first organ regeneration lab, AI-powered tool on surgical unit to improve patient care, Sexual assault survivors face significant barriers to care, Local cancer free after successful surgery - Energeticcity.ca, Ontario Nurses' Association says bargaining with, Major union joins community effort to save Lachine. The patients were categorized by vaccination interval into three groups of <1, 13, and 3 months. Methods: In this study, patients with adult trauma with subcutaneous sutures placed by a single plastic surgeon in a single center were included. Residents with wound issues frequently have comorbid conditions that put them at higher risk for developing serious consequences from COVID-19, said Karen Hoffmann, RN, MS, CIC, FSHEA, FAPIC, immediate past president of the Association for Professionals in Infection Control and Epidemiology. NSWOCs receive a competency-based education through the Wound, Ostomy and Continence Institute. doi: 10.1056/NEJMoa2110345, 15. In the span of 24 hours I was given Source codes and frequencies to assist in COVID . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. government site. (2019) 44:e79. COVID-19 vaccines also help protect against infection. Clipboard, Search History, and several other advanced features are temporarily unavailable. Numbers of patients, Each item of the POSAS patient scale. The Committee will meet in open session, to discuss, in general, the development, authorization and/or licensure of vaccines to prevent COVID-19. Clin Exp Dermatol. Based on the agencys preliminary assessment, and to allow more time to evaluate additional data, we believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization. Additionally, the agency will continue hosting virtual town halls for test developers for SARS-CoV-2 on July 27 and August 24 from 12:05 p.m. 1 p.m. The FDA formally accepts Priority Review designation for the Biologics License Application (BLA) for their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. All patients were diagnosed with simple and open skin injuries, which eliminated interference with the results by other comorbidities. doi: 10.1093/asj/sjz017, 20. Hospital News covers developments and issues that affect all health care professionals, administrators, patients, visitors and students. In English, her first language, Meera Varma has found the words to advocate for mental health at the White House, at school board meetings in her hometown of Burbank, on UCLA's campus and as a youth ambassador for Lady Gaga's Born This Way foundation. Neither of those sites of care can be considered safe for these compromised patients during this pandemic. COVID-19 Update: FDAs Ongoing Commitment to Transparency for COVID-19 EUAs. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Epub 2020 Jun 1. As part of the FDAs effort to protect consumers, on March 7, the agency issued a warning letter jointly with the Federal Trade Commission to Viraldine, LLC for selling unapproved products with fraudulent COVID-19 claims. Unauthorized use of these marks is strictly prohibited. Hospital News is published monthly and is made available in distribution racks placed in high traffic areas in hospitals and related institutions across the country. As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. However, global surveys have revealed that ~30% of participants were hesitant about COVID-19 vaccination (2, 3). In the critical months during which COVAX was created, signed on participants, pooled demand, and raised enough . (A) vascularization; (B) pigmentation; (C) thickness; (D), MeSH Dr. Peter Marks provides an update on COVID-19 vaccines and discusses the upcoming Vaccines and Related Biological Products Advisory Committee meeting. 8600 Rockville Pike Clinical images were obtained after patient consent after verification by a senior author (ZY, not publicly available). Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. This type of vaccine gives your cells instructions for how to make the S protein found on the surface of the COVID-19 virus. Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls. One surgeon performed the surgeries, which avoided the bias of different surgical techniques. Before Unable to load your collection due to an error, Unable to load your delegates due to an error. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Numbers of patients in groups of <1 month, 13 months, and 3 months were 8, 11, and 12, respectively. FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations. FDA In Brief: FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution, Making Vaccine More Widely Available. 10.1101/2020.12.28.20248950 Only 20% of people in low- and lower-middle-income countries have received a first dose of vaccine compared to 80% in high- and upper-middle income countries. FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks, FDA Commissioner Stephen Hahn on the Radio: COVID-19 & FDA. The FDA amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination. return to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the data, the weekend's EUA designation (Pfizer/BioNTech), and the process for future full licensure and postmarketing safety surveillance. (2016) 138:18S28S. In this study, patients with adult trauma with subcutaneous sutures placed by a single plastic surgeon in a single center were included. The results of each item for the WAI and POSAS scales are illustrated in Figures 35. The committee will discuss the Emergency Use Authorization (EUA) of the ModernaTX Inc. COVID-19 vaccine and the Janssen Biotech Inc. COVID-19 vaccine for the administration of an additional dose, or booster dose, following completion of the primary series, to individuals 18 years of age and older. Dr. Ann-Elizabeth further elaborated on the concerns of people of color getting the vaccine, saying, Historically, trials were mostly done on white men, but things have changed. To avoid the collapse of the healthcare system during the fight with COVID-19, all healthcare workers, including wound care practitioners, should adapt to new roles and use any appropriate methods available to slow the spread of the virus. It is posited that with 630 LTC facilities in Ontario, the fact that the majority of which are not serviced by an NSWOC is contributing to the persistently high prevalence of patients with WOC-related conditions in Ontario LTC facilities.. . 71 p. 19. I'm the FDA point person on COVID-19 vaccines. The pandemic has shed a light on the Ontario health care system and the need for nurses with advanced or enhanced knowledge of WOC conditions. Plast Reconstr Surg. Doctors also lack adequate evidence to address vaccine hesitancy, and many doctors are vaccine-hesitant themselves (4, 5). (June 17, 2022), A 1-page PDF infographic, also in: Espaol - Spanish (PDF-616KB) - Chinese (PDF-200KB) Tagalog (PDF-185KB) - Korean (PDF-242KB) Vit - Vietnamese (PDF-177KB) - Cherokee (PDF-249KB) Din Bizaad - Navajo (PDF-257KB), Diverse researchers and scientists who mirror the diversity in our communities have been developing vaccines to help protect us from COVID-19. Euro Surveill. , 1-844-802-39271-844-372-8337. (1:13), Espaol KoreanCantoneseMandarinTagalogVietnameseCherokeeNavajo, Typical vaccine development process starting in the lab through post-FDA-approval monitoring, Infographic on the path for vaccines from research to FDA approval, Ongoing FDA monitoring of COVID-19 vaccine safety, Dr. Peter Marks, Director of the FDA's Center for Biologics Evaluation and Research, answers questions about COVID-19 vaccines, FDA Commissioner, Dr. Robert Califf discusses COVID-19 vaccine boosters, RADM Araojo discusses FDAs Emergency Use Authorization process with RADM Denise Hinton, FDAs Chief Scientist, Director of the FDA's Center for Biologics Evaluation and Research discusses how the FDA facilitated COVID-19 vaccine development, How the FDA works to stop fraudulent products from reaching the market, Discussingwhether and how the composition for primary doses of the currently available COVID-19 vaccines should be modified and how and whether the composition and schedule for booster doses should be adjusted moving forward, Discussing whether and how to change the SARS-CoV-2 strain composition of COVID-19 vaccines, Discussing data for Modernas COVID-19 Vaccine for children 6 through 17 years of age, Moderna's COVID-19 Vaccine for children 6 months through 5 years of age, and Pfizer-BioNTech's COVID-19 Vaccine for children 6 months through 4 years of age, Discussing data for a Novavax COVID-19 vaccine for those 18 years of age and older, Discussing, in general, COVID-19 vaccine booster doses and strain selection, Discussing data for Pfizer COVID-19 Vaccine for children 5 - 11, Discussing Moderna COVID-19 Vaccine and Janssen COVID-19 Vaccine booster doses, Discussing a third dose or booster of a COVID-19 vaccine, Discussing pediatric use of COVID-19 vaccines, Discussing third emergency use authorization request for a COVID-19 vaccine, Discussing second emergency use authorization request for a COVID-19 vaccine, Discussing first emergency use authorization request for a COVID-19 vaccine, Discussing, in general, the development, authorization and/or licensure of vaccines to prevent COVID-19. 2020 Nov;2(4):100180. doi: 10.1016/j.ajogmf.2020.100180. *Correspondence: Zhou Yu, yz20080512@163.com; Xianjie Ma, majing@fmmu.edu.cn, COVID-19 Vaccines Safety Tracking (CoVaST): part I, View all This study has some limitations. XQ and SW: evaluating the scales and editing the manuscript. Also, the standard deviation (SD) of each group was 5. = 2, = 0.05, and = 0.2. sharing sensitive information, make sure youre on a federal In the spring of 2020, the Canadian military was deployed to several Ontario LTC facilities that were identified as needing staffing support and relief. However, no difference in scar formation among different vaccination interval groups was observed in this study. (A) edema; (B) erythema; (C) exudates. The .gov means its official. Each item of the POSAS patient scale. No differences in wound healing and scar formation were observed in patients with different COVID-19 vaccination intervals. It is created by eHealthMe based on reports of 15 people who have Wound infection from the Food and Drug Administration (FDA), and is updated regularly. Conclusion: -, Ward JK, Colgrove J, Verger P. France's risky vaccine mandates. Today, the FDA issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine. The FDA holds a stakeholder call with Vaccinate Your Family and pediatric and healthcare groups. View webcast, FDA Commissioner Talks to AARP About COVID-19 Vaccines. : , . doi: 10.1177/15347346221078734, 24. First, the follow-up to determine scar formation ended at 3 months because of the widespread prevalence of booster doses on the Chinese mainland.